We perform structure learning with a Hill Climb optimization algorithm, thus obtaining the best fitting Bayesian networks for the 11 variables (10 biomarkers and target PDFF)
Renew your glow
Int J Curr Microbiol Appl Sci 4:198224 Gupta A, Cheepurupalli L, Vigneswaran S, Rathore SS, Mohan SS, Ramakrishnan J (2020) In vitro and in silico investigation of caprylic acid effect on multi drug resistant (MDR) Klebsiella pneumoniae biofilm
PMID: 34676557 Purity & Documentation References Calculators Concentration (start) Volume (start) = Concentration (final) Volume (final)
Suitable aromatic amine containing biologically active moieties D are, for example, ( )-Carbovir, ( )-Hymenin, ( )-Norcisapride, ( )-Picumeterol, (R)-Aminoglutethimide, (R)-Clenbuterol, (S)-Aminoglutethimide, (S)-Clenbuterol, [6-p-aminophenylalanine]-angiotensin II, 10-Demethoxystreptonigrin, 17-Aminogeldanamycin, 1-Aminoacridine, 1-Deazaadenine, 1-NA-PP 1, 1-NM-PP 1, 2,7-Diaminoacridine, 2,7-Dimethylproflavine, 2-Amino-6(5H)-phenanthridinone, 2-Aminoacridine, 2-amino-Carbanilide, 2-Aminohistamine, 2-Aminoperimidine, 2- suitable drugs with aromatic amine groups may be selected from the list containing ( )-Draflazine, ( )-Indocarbazostatin B, (+)-(R)-Pramipexole, (R)-(+)-Terazosin, (R)-Ganciclovir Cyclic Phosphonate, (R)-Sufinosine, (R)-Zacopride, (S)-Sufinosine, (S)-Zacopride Hydrochloride, 17-Aminogeldanamycin, 2-Aminoaristeromycin, 2-Aminoneplanocin A, 3-Chloroprocainamide, 3-Deazaadenosine, 4-Aminosalicylic Acid, 4-Chlorophenylthio-DADME-Immucillin-A, 5-Homoneplanocin A, 5-Aminosalicylic Acid, 9-Aminocamptothecin, Abacavir Succinate, Abaca Suitable drugs with an amine group may be selected from the group consisting of Aphidicolin Glycinate, Cetrorelix Acetate, Picumeterol Fumarate, ( )-Draflazine, ( )-Indocarbazostatin B, (+)-(23,24)-Dihydrodiscodermolide, (+)-(R)-Pramipexole, (R)-(+)-Amlodipine, (R)-(+)-Terazosin, (R)-Ganciclovir Cyclic Phosphonate, (R)-Sufinosine, (R)-Zacopride, (S)-( )-Norketamine, (S)-Oxiracetam, (S)-Sufinosine, (S)-Zacopride Hydrochloride, [90Y]-DOTAGA-Substance P, [ARG(Me)9] MS-10, [D-TYR1,ARG(Me)9] MS-10 Suitable secondary amine-containing biologically active moieties may be selected from the group consisting of ( )-3-O-Acetylspectaline hydrochloride, ( )-3-O-tert-Boc-spectaline hydrochloride, ( )-Cicloprolol, ( )-Norchloro-[18F]fluoro-homoepibatidine, ( )-Salbutamol hydrochloride, ( )-Salmeterol, (+)-(S)-Hydroxychloroquine, (+)-Isamoltan, (+)-R-Pramipexole, (R)-(+)-Amlodipine, (R)-Clevidipine, (R)-NSP-307, (R)-Teludipine, (R)-Thionisoxetine, (S)-Clevidipine, (S)N-Desmethyltrimebutine, (S)-Noremop Suitable amine-containing biologically active moieties may also be selected from the group consisting of Fab (fragment, antigen-binding), F(ab)2 fragments, Fc (fragment, crystallizable), pFc fragment, Fv (fragment, variable), scFv (single-chain variable fragment), di-scFv/diabodies, bi-specific T-cell engager, CDRs (complementarity determining regions), single-domain antibodies (sdABs/Nanobodies), heavy chains ( , , , , ) or heavy chain fragments, light chains ( , ) or light chain fragments, VH fragments (variable region of the heavy chain), VL fragments (variable region of the light chain), VHH fragments, VNAR fragments, shark-derived antibody fragments and affinity scaffold proteins, Kunitz domain-derived affinity scaffold proteins, centyrin-derived affinity scaffold proteins, ubiquitin-derived affinity scaffold proteins, lipocalin-derived affinity scaffold proteins Suitable drugs containing aromatic hydroxyl groups are, for example, ( )-cis-Resorcylide, ( )-Indocarbazostatin B, ( )-Salmeterol, ( )-Subersic acid, (+)-alpha-Viniferin, (+)-Etorphine, (+)-Indocarbazostatin, (+)SCH-351448, (R)-Gossypol, (S)-(+)-Curcuphenol, (S)-Methylnaltrexone bromide, [8]-Gingerol, [Arg(Me)9] MS-10, [D-Tyr1,Arg(Me)9] MS-10, [D-Tyr1,AzaGly7,Arg(Me)9] MS-10, [D-Tyr1] MS-10, [psi[CH2NH]Tpg4]Vancomycin aglycon, [Trp19] MS-10, 13-Deoxyadria Suitable drugs with a hydroxyl group may be selected fromt the group consisting of ( )-(2R*,3R*,11bS*)-Dihydrotetrabenazine, ( )-(2R*,3S*,11bR*)-Dihydrotetrabenazine, ( )-2-(2-Bromohexadecanoyl)paclitaxel, ( )-4,5-Didemethoxypicropodophyllin, ( )-4-Demethoxypicropodophyllin, ( )-9-Dehydrogalanthaminium bromide, ( )-Calicheamicinone, ( )-Cicloprolol, ( )-cis-Resorcylide, ( )-Indocarbazostatin B, ( )-Kendomycin, ( )-Kolavenol, ( )-Salmeterol, ( )-Subersic Suitable drugs with carboxyl groups may be be selected from the list containing ( )-Subersic acid, (+)-Deoxoartelinic acid, (+)-Hemipalmitoylcarnitinium, (+)-Indobufen, (+)-SCH-351448, (E)-p-Coumaroylquinic acid, (Z)-Indenaprost, [111In-DTPA-Pro1,Tyr4]bombesin, [90Y]-DOTAGA-substance P, [psi[CH2NH]Tpg4]Vancomycin aglycon, 111In-Pentetreotide, 11-Keto-Beta-Boswellic Acid, 15-Methoxypinusolidic acid, 1-Methyl-D-tryptophan, 3,5-Dicaffeoylquinic acid, 3-MATIDA, 3-O-Acetyloleanolic acid, 4-Aminosalicylic acid, 6alpha-F Suitable drugs with a phosphate group may be selected fromt the group consisting of Adenophostin A, Adenophostin B, Atrinositol, Buflomedil pyridoxalphosphate, Cytostatin, Fludarabine phosphate, Fosfluconazole, Fosfonochlorin, Fosfosal, Fosopamine, Fosquidone, Fostamatinib, Ganciclovir monophosphate, Genistein-7-phosphate, Hydroxyphoslactomycin B, Leustroducsin A, Leustroducsin B, Leustroducsin C, Leustroducsin H, Mangafodipir trisodium, Menadiol sodium diphosphate, Miproxifene phosphate, Monophosphoryl lipid A, Phospholine, Phosphosalsalate, Pneumocandin B0 2-phosphate, Tafluposide, Triciribine phosphate, Ursolic acid phosphate
